company background image
VHT

Volpara Health Technologies ASX:VHT Stock Report

Last Price

AU$0.48

Market Cap

AU$121.0m

7D

-12.7%

1Y

-60.3%

Updated

25 Sep, 2022

Data

Company Financials +
VHT fundamental analysis
Snowflake Score
Valuation4/6
Future Growth5/6
Past Performance0/6
Financial Health4/6
Dividends0/6

VHT Stock Overview

Volpara Health Technologies Limited provides breast imaging analytics software products in New Zealand.

Volpara Health Technologies Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Volpara Health Technologies
Historical stock prices
Current Share PriceAU$0.48
52 Week HighAU$1.32
52 Week LowAU$0.40
Beta1.07
1 Month Change-21.95%
3 Month Change18.52%
1 Year Change-60.33%
3 Year Change-70.09%
5 Year Change-25.00%
Change since IPO-4.00%

Recent News & Updates

Shareholder Returns

VHTAU Healthcare ServicesAU Market
7D-12.7%-3.7%-2.7%
1Y-60.3%-24.8%-11.0%

Return vs Industry: VHT underperformed the Australian Healthcare Services industry which returned -24.8% over the past year.

Return vs Market: VHT underperformed the Australian Market which returned -11% over the past year.

Price Volatility

Is VHT's price volatile compared to industry and market?
VHT volatility
VHT Average Weekly Movement11.5%
Healthcare Services Industry Average Movement11.5%
Market Average Movement9.6%
10% most volatile stocks in AU Market16.9%
10% least volatile stocks in AU Market4.3%

Stable Share Price: VHT is not significantly more volatile than the rest of Australian stocks over the past 3 months, typically moving +/- 12% a week.

Volatility Over Time: VHT's weekly volatility (12%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2009189Teri Thomashttps://www.volparahealth.com

Volpara Health Technologies Limited provides breast imaging analytics software products in New Zealand. The company offers Volpara Analytics, a software that optimize breast cancer screening operations; Volpara Live, which provides instant patient-based image quality feedback; Volpara Lung, a patient management software that streamlines lung screening workflow; and Volpara Patient Hub, a customizable mammography reporting and patient communications software. It also offers Volpara Risk, an integration with Patient Hub that uses TC8 to calculate patients’ risk of developing breast cancer; Volpara Risk Pathways, a program for identifying and managing high-risk breast cancer screening patients; Volpara Scorecard, which displays patient breast density and risk insights essential for improved clinical decision-making and early detection; and Volpara Science, an AI-based software that powers Volpara software products.

Volpara Health Technologies Fundamentals Summary

How do Volpara Health Technologies's earnings and revenue compare to its market cap?
VHT fundamental statistics
Market CapAU$120.98m
Earnings (TTM)-AU$14.48m
Revenue (TTM)AU$23.01m

5.3x

P/S Ratio

-8.4x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
VHT income statement (TTM)
RevenueNZ$26.11m
Cost of RevenueNZ$2.29m
Gross ProfitNZ$23.82m
Other ExpensesNZ$40.26m
Earnings-NZ$16.44m

Last Reported Earnings

Mar 31, 2022

Next Earnings Date

n/a

Earnings per share (EPS)-0.065
Gross Margin91.23%
Net Profit Margin-62.96%
Debt/Equity Ratio0.5%

How did VHT perform over the long term?

See historical performance and comparison
We’ve recently updated our valuation analysis.

Valuation

Is VHT undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

4/6

Valuation Score 4/6

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Below Fair Value

  • Significantly Below Fair Value

  • Analyst Forecast

Key Valuation Metric

Which metric is best to use when looking at relative valuation for VHT?

Other financial metrics that can be useful for relative valuation.

VHT key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue4.6x
Enterprise Value/EBITDA-8.3x
PEG Ration/a

Price to Sales Ratio vs Peers

How does VHT's PS Ratio compare to its peers?

VHT PS Ratio vs Peers
The above table shows the PS ratio for VHT vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyPSEstimated GrowthMarket Cap
Peer Average13.6x
M7T Mach7 Technologies
5x18.2%AU$134.9m
ALC Alcidion Group
5x17.6%AU$171.2m
CGS Cogstate
3.6x18.1%AU$247.9m
PCK PainChek
40.8x58.9%AU$40.2m
VHT Volpara Health Technologies
5.3x22.0%AU$121.0m

Price-To-Sales vs Peers: VHT is good value based on its Price-To-Sales Ratio (5.3x) compared to the peer average (13.6x).


Price to Earnings Ratio vs Industry

How does VHT's PE Ratio compare vs other companies in the AU Healthcare Services Industry?

Price-To-Sales vs Industry: VHT is expensive based on its Price-To-Sales Ratio (5.3x) compared to the Australian Healthcare Services industry average (5x)


Price to Sales Ratio vs Fair Ratio

What is VHT's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

VHT PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio5.3x
Fair PS Ratio11.1x

Price-To-Sales vs Fair Ratio: VHT is good value based on its Price-To-Sales Ratio (5.3x) compared to the estimated Fair Price-To-Sales Ratio (11.1x).


Share Price vs Fair Value

What is the Fair Price of VHT when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: VHT (A$0.48) is trading below our estimate of fair value (A$1.09)

Significantly Below Fair Value: VHT is trading below fair value by more than 20%.


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.


Discover undervalued companies

Future Growth

How is Volpara Health Technologies forecast to perform in the next 1 to 3 years based on estimates from 4 analysts?

Future Growth Score

5/6

Future Growth Score 5/6

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE


88.9%

Forecasted annual earnings growth

Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: VHT is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (1.8%).

Earnings vs Market: VHT is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: VHT is expected to become profitable in the next 3 years.

Revenue vs Market: VHT's revenue (22% per year) is forecast to grow faster than the Australian market (3.7% per year).

High Growth Revenue: VHT's revenue (22% per year) is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: VHT's Return on Equity is forecast to be low in 3 years time (0.4%).


Discover growth companies

Past Performance

How has Volpara Health Technologies performed over the past 5 years?

Past Performance Score

0/6

Past Performance Score 0/6

  • Quality Earnings

  • Growing Profit Margin

  • Earnings Trend

  • Accelerating Growth

  • Earnings vs Industry

  • High ROE


-16.7%

Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: VHT is currently unprofitable.

Growing Profit Margin: VHT is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: VHT is unprofitable, and losses have increased over the past 5 years at a rate of 16.7% per year.

Accelerating Growth: Unable to compare VHT's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: VHT is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare Services industry (-0.1%).


Return on Equity

High ROE: VHT has a negative Return on Equity (-28.4%), as it is currently unprofitable.


Discover strong past performing companies

Financial Health

How is Volpara Health Technologies's financial position?

Financial Health Score

4/6

Financial Health Score 4/6

  • Short Term Liabilities

  • Long Term Liabilities

  • Debt Level

  • Reducing Debt

  • Stable Cash Runway

  • Forecast Cash Runway

Financial Position Analysis

Short Term Liabilities: VHT's short term assets (NZ$30.4M) exceed its short term liabilities (NZ$20.9M).

Long Term Liabilities: VHT's short term assets (NZ$30.4M) exceed its long term liabilities (NZ$2.2M).


Debt to Equity History and Analysis

Debt Level: VHT has more cash than its total debt.

Reducing Debt: VHT's debt to equity ratio has increased from 0.03% to 0.5% over the past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: VHT has sufficient cash runway for more than a year based on its current free cash flow.

Forecast Cash Runway: Insufficient data to determine if VHT has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.


Discover healthy companies

Dividend

What is Volpara Health Technologies's current dividend yield, its reliability and sustainability?

Dividend Score

0/6

Dividend Score 0/6

  • Notable Dividend

  • High Dividend

  • Stable Dividend

  • Growing Dividend

  • Earnings Coverage

  • Cash Flow Coverage

Dividend Yield vs Market

Notable Dividend: Unable to evaluate VHT's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate VHT's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if VHT's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if VHT's dividend payments have been increasing.


Earnings Payout to Shareholders

Earnings Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as VHT has not reported any payouts.


Discover strong dividend paying companies

Management

How experienced are the management team and are they aligned to shareholders interests?

2.8yrs

Average management tenure


CEO

Teri Thomas

0.42yr

Tenure

Ms. Teri Thomas is Chief Executive Officer of Volpara Health Technologies Limited from April 2022. She served as an Executive Vice President of Global Sales, Marketing & Strategy at Orion Health Group Limi...


Leadership Team

Experienced Management: VHT's management team is considered experienced (2.8 years average tenure).


Board Members

Experienced Board: VHT's board of directors are considered experienced (4.5 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: VHT insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

ASX:VHT Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
29 Jun 22BuyAU$28,610John PavlidisIndividual69,100AU$0.41
22 Jun 22BuyAU$13,500John DiddamsIndividual30,000AU$0.45
17 Jun 22BuyAU$2,020,226Harbour Asset Management LimitedCompany3,266,525AU$0.62
16 Jun 22BuyAU$16,801John DiddamsIndividual30,001AU$0.56
15 Jun 22BuyAU$66,959Paul Robert ReidIndividual115,000AU$0.58
10 May 22SellAU$415,905Harbour Asset Management LimitedCompany541,280AU$0.77
23 Mar 22BuyAU$3,306,802Harbour Asset Management LimitedCompany3,553,098AU$0.93
09 Mar 22SellAU$1,046,884Harbour Asset Management LimitedCompany964,153AU$1.09
13 Dec 21SellAU$493First NZ Capital Ltd., Asset Management ArmCompany500AU$0.99

Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 25 shareholders own 41.44% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
12.1%
Harbour Asset Management Limited
30,497,287NZ$14.6m7.2%1.98%
7.33%
Roger Allen
18,467,848NZ$8.9m0%no data
6.43%
Ralph Highnam
16,213,561NZ$7.8m0%no data
2.82%
John Brady
7,119,075NZ$3.4m0%no data
2.37%
Marcus Sarner
5,980,404NZ$2.9m0%no data
1.84%
Norges Bank Investment Management
4,636,610NZ$2.2m0%no data
1.19%
Martin Wood
3,004,655NZ$1.4m0%no data
1.19%
Lady Wood
3,004,654NZ$1.4m0%no data
0.82%
Martin Yaffe
2,066,483NZ$991.9k0%no data
0.82%
Causeway Capital Management LLC
2,063,870NZ$990.7k1684.71%no data
0.74%
Schroder Investment Management North America Inc.
1,858,077NZ$891.9k0%no data
0.72%
Nico Karssemeijer
1,806,806NZ$867.3k0%no data
0.6%
Horizon 3 Biotech Fund
1,519,964NZ$729.6k0%no data
0.54%
Martin Smith
1,366,977NZ$656.1k0%no data
0.51%
John Dell
1,288,864NZ$618.7k0%no data
0.48%
John Diddams
1,202,295NZ$577.1k0%no data
0.36%
Artemis Investment Management LLP
910,647NZ$437.1k16.93%no data
0.17%
Baillie Gifford & Co.
419,272NZ$201.3k1635.4%no data
0.11%
State Street Global Advisors, Inc.
282,800NZ$135.7k0.9%no data
0.11%
Dimensional Fund Advisors LP
268,749NZ$129.0k0%no data
0.071%
Bellatrix Asset Management S.A.
180,000NZ$86.4k0%0.03%
0.046%
Paul Robert Reid
115,000NZ$55.2k0%no data
0.032%
Monica Saini
80,000NZ$38.4k0%no data
0.027%
John Pavlidis
69,100NZ$33.2k0%no data
0.0095%
First NZ Capital Ltd., Asset Management Arm
24,082NZ$11.6k0%no data

Company Information

Volpara Health Technologies Limited's employee growth, exchange listings and data sources


Key Information

  • Name: Volpara Health Technologies Limited
  • Ticker: VHT
  • Exchange: ASX
  • Founded: 2009
  • Industry: Health Care Technology
  • Sector: Healthcare
  • Implied Market Cap: AU$120.984m
  • Shares outstanding: 252.05m
  • Website: https://www.volparahealth.com

Number of Employees


Location

  • Volpara Health Technologies Limited
  • Simpl House
  • Level 14
  • Wellington
  • 6011
  • New Zealand


Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
VHTASX (Australian Securities Exchange)YesOrdinary SharesAUAUDApr 2016
VHTCHIA (Chi-X Australia)YesOrdinary SharesAUAUDApr 2016
VPAH.FOTCPK (Pink Sheets LLC)YesOrdinary SharesUSUSDApr 2016

Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2022/09/25 00:00
End of Day Share Price2022/09/23 00:00
Earnings2022/03/31
Annual Earnings2022/03/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.